Using drugs that inhibit enzymes called CDK4/6 and CDK2 extends the G1 phase of the cell cycle and helps to slow the growth of drug-resistant breast cancer.
Rb1 loss may serve as a predictive biomarker to guide new targeted therapies for select breast cancers resistant to standard ...
Motixafortide alone and in combination with natalizumab can support the collection of the large number of stem cells required by gene therapies for sickle cell disease within a single apheresis cycle ...
Study Finds on MSN
Cannabis compounds stop ovarian cancer cells from surviving in lab tests
A pair of well-known marijuana compounds work in tandem to target ovarian cancer cells In A Nutshell CBD and THC killed ...
When cell division (mitosis) takes too long, it can be a sign that something is wrong with the cells, for example DNA damage or chromosomal instability. That’s why our cells come with an innate ...
A new study published in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center ...
News Medical on MSN
Researchers identify Rb1 as a predictive biomarker for a new therapeutic strategy in some breast cancers
A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center details a therapeutic vulnerability in patients with an aggressive ...
A quick revision guide covering key concepts, biomolecules, cell organelles, and essential NEET-style MCQs to boost exam preparation.
Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced the nomination of CID-165, a first-in-class, ...
Discover how axolotls and flatworms coordinate regeneration through body-wide signals, revealing a complex healing process.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback